NEW YORK (GenomeWeb News) — Boehringer Ingelheim will use BioMax’s BioRS Integration and Retrieval system as a data-integration platform to access public and private pharmaceutical information, BioMax said yesterday.
 
BioRS is designed to search multiple databases through web interfaces.
 
Financial terms of the agreement were not released.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

A federal grand jury has indicted Elizabeth Holmes and Ramesh Balwani for alleged wire fraud in conjunction with their activities at Theranos.

A direct-to-consumer genetic testing company sent out used spit kits, CNBC reports.

Nature News reports that some developers are nervous about GitHub's acquisition by Microsoft.

In PLOS this week: comparison of commercial bisulfite kits, new method to predict essential proteins, and more